1834 Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,100
Closed -$68K 298
2022
Q2
$68K Sell
1,100
-275
-20% -$17K 0.01% 250
2022
Q1
$82K Hold
1,375
0.01% 230
2021
Q4
$100K Hold
1,375
0.01% 231
2021
Q3
$96K Hold
1,375
0.01% 231
2021
Q2
$95K Sell
1,375
-2,285
-62% -$153K 0.01% 237
2021
Q1
$237K Buy
3,660
+2,285
+166% +$147K 0.03% 184
2020
Q4
$80K Hold
1,375
0.01% 240
2020
Q3
$87K Hold
1,375
0.01% 234
2020
Q2
$106K Sell
1,375
-500
-27% -$38.3K 0.02% 217
2020
Q1
$140K Buy
1,875
+275
+17% +$19K 0.03% 201
2019
Q4
$104K Buy
1,600
+1,000
+167% +$65.1K 0.02% 238
2019
Q3
$38K Sell
600
-130
-18% -$8.5K 0.01% 290
2019
Q2
$50K Buy
730
+130
+22% +$8.55K 0.01% 284
2019
Q1
$39K Hold
600
0.01% 294
2018
Q4
$38K Sell
600
-120
-17% -$8.39K 0.01% 285
2018
Q3
$56K Hold
720
0.01% 270
2018
Q2
$51K Hold
720
0.01% 271
2018
Q1
$54K Sell
720
-108
-13% -$8.59K 0.01% 266
2017
Q4
$59K Buy
+828
New +$62.9K 0.01% 279
2016
Q1
Sell
-26,693
Closed -$2.7M 175
2015
Q4
$2.7M Buy
26,693
+765
+3% +$79.6K 0.63% 54
2015
Q3
$2.55M Sell
25,928
-910
-3% -$101K 0.63% 53
2015
Q2
$3.14M Buy
26,838
+1,263
+5% +$138K 0.86% 40
2015
Q1
$2.51M Buy
+25,575
New +$2.6M 0.68% 45

Other funds holding GILD

1834 Investment Advisors's GILD Position: Q3 2022 in Review

1834 Investment Advisors sold out of Gilead Sciences (GILD) in Q3 2022, closing a stake of 1,100 shares — an estimated $68K sold.

1834 Investment Advisors first reported a position in GILD in Q1 2015 and held it in 23 quarters. The position peaked at $3.14M in Q2 2015. 1,602 funds tracked by Wall St. Rank hold GILD as of Q3 2022.

  • 1834 Investment Advisors reported no remaining Gilead Sciences position as of Q3 2022 after selling out during the quarter.
  • 1834 Investment Advisors sold 1,100 Gilead Sciences shares in Q3 2022, an estimated $68K.
  • 1834 Investment Advisors first reported a position in Gilead Sciences in Q1 2015 and held it in 23 quarters.
  • 1834 Investment Advisors's Gilead Sciences position peaked at $3.14M in Q2 2015.
  • 1,602 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2022.

Based on 1834 Investment Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.